Adrafinil is a synthetic nootropic that is chemically very similar to Modafinil. In fact, Adrafinil works by increasing the levels of Modafinil in the body. Therefore, pharmacological effects of these two compounds are pretty much identical. Adrafinil was originally developed by a French pharmaceutical company and until 2011 marketed under the brand name of Olmifon. Adrafinil is a cognitive-enhancing therapeutic (CET) compound designed to relieve excessive daytime sleepiness and inattention in elderly patients. Modafinil (bioactive metabolite of Adrafinil) is an effective wakefulness promoting agent used by people with other disorders, such as Parkinson’s disease, multiple sclerosis, depression and obstructive sleep apnoea. Due to its effects, Adrafinil is often used to treat narcolepsy, sleep and attention disorders and is well-known for its ability to promote alertness and wakefulness. That is why Adrafinil is classified as an eugeroic (“the good arousal”) agent.